ÀÚµ¿¿Ï¼º ¿­±â
ÀÚµ¿¿Ï¼º ´Ý±â
¿¹ÆÇ»ó¼¼°Ë»ö
¿¹ÆÇ »ó¼¼°Ë»ö
»ý»êÀÏÀÚ  ~ ÃÖ±Ù 1°³¿ù ÃÖ±Ù 6°³¿ù 1³â 3³â 5³â Àüü
°Ë»ö¹æ¹ý
»ý»ê±â°ü »ý»ê±â°ü ¼±ÅÃ
¡Ø »ý»ê±â°üÀ» ¼±ÅÃÇÏ½Ã¸é º¸´Ù Á¤È®ÇÏ°Ô ¹®¼­¹øÈ£¸¦ È®ÀÎÇÏ½Ç ¼ö ÀÖ½À´Ï´Ù.
»ý»ê±â°ü
  • »ý»êÀÏÀڴ Ķ¸°´õ ¼±Åà ¶Ç´Â Á÷Á¢ ÀÔ·ÂÀ¸·Î ¼³Á¤ÀÌ °¡´ÉÇÕ´Ï´Ù. (ÀÔ·Â ¿¹½Ã: 2018-03-20)
  • ¹®¼­¹øÈ£ ¶Ç´Â ÀÓÀÇ¾î °Ë»öÀ» ¼±ÅÃÇÏ¿© °Ë»öÇÒ ¼ö ÀÖ½À´Ï´Ù.
  • ¹®¼­¹øÈ£ °Ë»ö ½Ã »ý»ê±â°ü ¼±Åà ¾øÀÌ ¹®¼­¹øÈ£ ÀüüÀÔ·Â ¶Ç´Â µÞ ¹øÈ£·Î °Ë»öÇÏ½Ã¸é Æí¸®ÇÕ´Ï´Ù. (¹øÈ£ °¡Àå ù¹øÂ° 0ÀÌ ÀÖÀ» °æ¿ì 0À» Á¦¿ÜÇÑ ¼ýÀÚÀÔ·Â)
    ¿¹1) »çÀü¹ý·É¹ýÀÎ-560 or 560,  ¿¹2) Á¶½É2016Áß4304 or 4304,  ¿¹3) »çÀü¹ý·É¼Òµæ-0717(X) ¡æ »çÀü¹ý·É¼Òµæ-717(¤·)
  • ÀÓÀÇ¾î °Ë»ö ½Ã ¼¼¸ñ±¸ºÐÀ» Ȱ¿ëÇÏ¿© °Ë»ö¹üÀ§¸¦ ¼³Á¤ÇÏ½Ç ¼ö ÀÖ½À´Ï´Ù.
¿øÇÏ´Â °Ë»ö Á¶°ÇÀ» ¼±ÅÃÇϰí '°Ë»ö' ¹öưÀ» Ŭ¸¯Çϼ¼¿ä.
ȸ°è
ȸ°è±âÁØ È¸°è°¨»ç ȸ°è½Ç¹«
Àüü : 280°Ç
¹®¼­¹øÈ£ / ¿äÁö(Á¦¸ñ)
EECS/0122-11, 2022.09.07 Çö±Ý ¹× Çö±Ý¼ºÀÚ»êÀÇ ±¸¼º º¯°æ(Change in the composition of cash and cash equivalents)
EECS/0122-10, 2022.09.07 ¿µ¾÷ ºÎ¹®(Operating Segments)
EECS/0122-09, 2022.09.07 Çö±ÝâÃâ´ÜÀ§ÀÇ ½Äº°(Identifying cash-generating units (GGUs))
EECS/0122-08, 2022.09.07 COVID-19 ¼Õ»ó ÁöÇ¥(COVID-19 impairment indicators)
EECS/0122-07, 2022.09.07 »ç¿ë±ÇÀÚ»êÀ¸·Î ±¸¼ºµÈ Çö±ÝâÃâ´ÜÀ§ÀÇ ¼Õ»ó°Ë»ç(Impairment test of cash generating unit comprising right of use assets)
EECS/0122-06, 2022.09.07 ¼Ò¼Û ¼öÀÍÀÇ Ç¥½Ã(Presentation of litigation proceeds as revenue)
EECS/0122-05, 2022.09.07 À¯ÀÇÀûÀÎ ±ÝÀ¶ ¿ä¼Ò(Significant financing component)
EECS/0122-04, 2022.09.07 ½Ã°£ °æ°ú¿¡ µû¸¥ ¼öÀÍ ÀνÄ(Recognition of revenue over time)
EECS/0122-03, 2022.09.07 Àç°íÀÚ»ê ¼ø½ÇÇö°¡´É°¡Ä¡¸¦ °è»êÇÒ ¶§ÀÇ ÆÇ¸Åºñ¿ë(Costs to make the sale in calculating the net realisable value of inventories)
EECS/0122-02, 2022.09.07 Àç°íÀÚ»ê ¼ø½ÇÇö°¡´É°¡Ä¡ ÃøÁ¤(Measurement of net realisable value of inventory)